Rapid Dose Therapeutics RDTCF Stock
Rapid Dose Therapeutics Price Chart
Rapid Dose Therapeutics RDTCF Financial and Trading Overview
| Rapid Dose Therapeutics stock price | 0.06 USD |
| Previous Close | 0.06 USD |
| Open | 0.06 USD |
| Bid | 0.06 USD x 3000000 |
| Ask | 0.07 USD x 2000000 |
| Day's Range | 0.06 - 0.06 USD |
| 52 Week Range | 0.006 - 0.15 USD |
| Volume | 10K USD |
| Avg. Volume | 1.71K USD |
| Market Cap | 8.11M USD |
| Beta (5Y Monthly) | -0.909 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RDTCF Valuation Measures
| Enterprise Value | 13.98M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.1497567 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.428 |
| Enterprise Value/EBITDA | -7.647 |
Trading Information
Rapid Dose Therapeutics Stock Price History
| Beta (5Y Monthly) | -0.909 |
| 52-Week Change | -43.88% |
| S&P500 52-Week Change | 19.88% |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.006 USD |
| 50-Day Moving Average | 0.06 USD |
| 200-Day Moving Average | 0.09 USD |
RDTCF Share Statistics
| Avg. Volume (3 month) | 1.71K USD |
| Avg. Daily Volume (10-Days) | 846 USD |
| Shares Outstanding | 135.18M |
| Float | 115.71M |
| Short Ratio | N/A |
| % Held by Insiders | 17.02% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | February 28, 2026 |
| Most Recent Quarter (mrq) | May 31, 2026 |
| Next Fiscal Year End | February 28, 2027 |
Profitability
| Profit Margin | -123.089% |
| Operating Margin (ttm) | -38.95% |
| Gross Margin | 49.83% |
| EBITDA Margin | -70.98% |
Management Effectiveness
| Return on Assets (ttm) | -33.29% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.58M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | -25.30% |
| Gross Profit (ttm) | 1.28M USD |
| EBITDA | -1827956 USD |
| Net Income Avi to Common (ttm) | -3169686 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.65K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 5.81M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.037 |
| Book Value Per Share (mrq) | -0.03756852 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 210.69K USD |
| Levered Free Cash Flow (ttm) | -202721 USD |
Profile of Rapid Dose Therapeutics
| Country | United States |
| State | ON |
| City | Burlington |
| Address | 1121 Walker's Line |
| ZIP | L7N 2G4 |
| Phone | 416-477-1052 |
| Website | https://rapid-dose.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system designed to rapidly release pharmaceuticals, emulsified oils, and over-the-counter medicines into the bloodstream. It also provides over-the-counter products consisting of QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12; and QuickStrip Sleep to deliver melatonin, as well as dental products including Lidocaine QuickStrip, a muco-adhesive oral thin film. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips containing active ingredients. In addition, the company is involved in the sale of health and wellness products, such as nutraceuticals; white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing; and the provision of consulting services for the application of active ingredients with the oral thin film polymer formulation and processes. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.
Q&A For Rapid Dose Therapeutics Stock
What is a current RDTCF stock price?
Rapid Dose Therapeutics RDTCF stock price today per share is 0.06 USD.
How to purchase Rapid Dose Therapeutics stock?
You can buy RDTCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rapid Dose Therapeutics?
The stock symbol or ticker of Rapid Dose Therapeutics is RDTCF.
Which industry does the Rapid Dose Therapeutics company belong to?
The Rapid Dose Therapeutics industry is Biotechnology.
How many shares does Rapid Dose Therapeutics have in circulation?
The max supply of Rapid Dose Therapeutics shares is 135.18M.
What is Rapid Dose Therapeutics Price to Earnings Ratio (PE Ratio)?
Rapid Dose Therapeutics PE Ratio is now.
What was Rapid Dose Therapeutics earnings per share over the trailing 12 months (TTM)?
Rapid Dose Therapeutics EPS is -0.02 USD over the trailing 12 months.
Which sector does the Rapid Dose Therapeutics company belong to?
The Rapid Dose Therapeutics sector is Healthcare.
